Loading organizations...
ApoWiser: AI digital health platform providing personalized virtual pharmacist guidance for OTC medications and supplements to pharmacy chains.
Based in Israel with additional operations in the United Kingdom, ApoWiser is a digital health platform that functions as an artificial intelligence-powered virtual pharmacist to help consumers safely select over-the-counter medications and dietary supplements. Operating on a business-to-business-to-consumer software-as-a-service model, the system analyzes user symptoms, medical history, and potential drug interactions to deliver clinically validated product recommendations. The company licenses its proprietary technology to retail pharmacy chains, health maintenance organizations, and online healthcare retailers, successfully integrating its platform into the digital e-commerce site of Super-Pharm. Backed by seed funding from the digital health incubator eHealth Ventures, the enterprise currently operates with a dedicated team of six employees. ApoWiser was founded in 2021 by Moran Shoham, Paul de Redelijkheid, Eldad Aharoni, and Eyal Schwartzberg, the former Head of Pharmacy Services at the Israeli Ministry of Health.
ApoWiser has raised $1.5M across 1 funding round.
ApoWiser has raised $1.5M in total across 1 funding round.
ApoWiser has raised $1.5M in total across 1 funding round.
ApoWiser's investors include Longliv Ventures.
ApoWiser has raised $1.5M across 1 funding round. Most recently, it raised $1.5M Seed in June 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 22, 2022 | $1.5M Seed | Longliv Ventures |